These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 8989922)
1. Combined effect of tamoxifen or interferon-beta and 4-hydroxyphenylretinamide on the growth of breast cancer cell lines. Coradini D; Biffi A; Pellizzaro C; Pirronello E; Di Fronzo G Tumour Biol; 1997; 18(1):22-9. PubMed ID: 8989922 [TBL] [Abstract][Full Text] [Related]
2. Tamoxifen and beta-interferon: effect of simultaneous or sequential treatment on breast cancer cell lines. Coradini D; Biffi A; Pirronello E; Di Fronzo G Anticancer Res; 1995; 15(2):315-9. PubMed ID: 7763000 [TBL] [Abstract][Full Text] [Related]
3. Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines. Favoni RE; de Cupis A; Bruno S; Yee D; Ferrera A; Pirani P; Costa A; Decensi A Br J Cancer; 1998 Jun; 77(12):2138-47. PubMed ID: 9649125 [TBL] [Abstract][Full Text] [Related]
4. Experimental studies on the effects of the combined use of N-(4-hydroxyphenyl)retinamide (4-HPR) and tamoxifen (TAM) for estrogen receptor (ER)-negative breast cancer. Aoyama Y Kurume Med J; 2002; 49(1-2):27-33. PubMed ID: 12235869 [TBL] [Abstract][Full Text] [Related]
5. The effect of ICI 164384 and beta-interferon on the growth and steroid receptor profile of breast cancer cell lines. Coradini D; Biffi A; Pirronello E; Di Fronzo G Anticancer Res; 1995; 15(6B):2557-61. PubMed ID: 8669823 [TBL] [Abstract][Full Text] [Related]
6. Growth inhibition of human in vitro and mouse in vitro and in vivo mammary tumor models by retinoids in comparison with tamoxifen and the RU-486 anti-progestagen. Darro F; Cahen P; Vianna A; Decaestecker C; Nogaret JM; Leblond B; Chaboteaux C; Ramos C; Pétein M; Budel V; Schoofs A; Pourrias B; Kiss R Breast Cancer Res Treat; 1998 Sep; 51(1):39-55. PubMed ID: 9877028 [TBL] [Abstract][Full Text] [Related]
7. A novel mechanism by which N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell growth: the production of nitric oxide. Simeone AM; Ekmekcioglu S; Broemeling LD; Grimm EA; Tari AM Mol Cancer Ther; 2002 Oct; 1(12):1009-17. PubMed ID: 12481423 [TBL] [Abstract][Full Text] [Related]
8. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism. Maurer BJ; Melton L; Billups C; Cabot MC; Reynolds CP J Natl Cancer Inst; 2000 Dec; 92(23):1897-909. PubMed ID: 11106681 [TBL] [Abstract][Full Text] [Related]
9. The interferon-beta and tamoxifen combination induces apoptosis using thioredoxin reductase. Lindner DJ; Hofmann ER; Karra S; Kalvakolanu DV Biochim Biophys Acta; 2000 Apr; 1496(2-3):196-206. PubMed ID: 10771088 [TBL] [Abstract][Full Text] [Related]
10. The effect of tamoxifen and fenretinimide on human colorectal cancer cell lines in vitro. Ziv Y; Gupta MK; Milsom JW; Vladisavljevic A; Brand M; Fazio VW Anticancer Res; 1994; 14(5A):2005-9. PubMed ID: 7847841 [TBL] [Abstract][Full Text] [Related]
11. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines. Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676 [TBL] [Abstract][Full Text] [Related]
12. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines. Kazmi SM; Plante RK; Visconti V; Lau CY Cancer Res; 1996 Mar; 56(5):1056-62. PubMed ID: 8640761 [TBL] [Abstract][Full Text] [Related]
13. Synergistic antitumor effects of a combination of interferon and tamoxifen on estrogen receptor-positive and receptor-negative human tumor cell lines in vivo and in vitro. Lindner DJ; Borden EC J Interferon Cytokine Res; 1997 Nov; 17(11):681-93. PubMed ID: 9402106 [TBL] [Abstract][Full Text] [Related]
14. Synergistic cytotoxic effects of tumor necrosis factor, interferon-gamma and tamoxifen on breast cancer cell lines. Matsuo S; Takano S; Yamashita J; Ogawa M Anticancer Res; 1992; 12(5):1575-9. PubMed ID: 1444224 [TBL] [Abstract][Full Text] [Related]
15. Combined effects of 13-cis-retinoic acid, tamoxifen and interferon on the growth of human breast cancer cells. Lama G; Angelucci C; Recchia F; Sica G Cancer Lett; 1996 Feb; 100(1-2):181-9. PubMed ID: 8620440 [TBL] [Abstract][Full Text] [Related]
17. Influence of different combinations of tamoxifen and toremifene on estrogen receptor-positive breast cancer cell lines. Coradini D; Biffi A; Cappelletti V; Di Fronzo G Cancer Detect Prev; 1995; 19(4):348-54. PubMed ID: 7553677 [TBL] [Abstract][Full Text] [Related]
18. Hesperidin, piperine and bee venom synergistically potentiate the anticancer effect of tamoxifen against breast cancer cells. Khamis AAA; Ali EMM; El-Moneim MAA; Abd-Alhaseeb MM; El-Magd MA; Salim EI Biomed Pharmacother; 2018 Sep; 105():1335-1343. PubMed ID: 30021371 [TBL] [Abstract][Full Text] [Related]
19. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma. Sheikh MS; Shao ZM; Li XS; Ordonez JV; Conley BA; Wu S; Dawson MI; Han QX; Chao WR; Quick T Carcinogenesis; 1995 Oct; 16(10):2477-86. PubMed ID: 7586155 [TBL] [Abstract][Full Text] [Related]
20. beta-Sitosterol enhances tamoxifen effectiveness on breast cancer cells by affecting ceramide metabolism. Awad AB; Barta SL; Fink CS; Bradford PG Mol Nutr Food Res; 2008 Apr; 52(4):419-26. PubMed ID: 18338406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]